Therapy Devices Panel News Today

Some failed to meet regulatory standards, skin pigmentation remains an issue

Panel concentrated on how to ensure the accuracy of pulse oximeters for all skin tones before they reach drugstore shelves.

The longstanding problem of pulse oximeters providing less-accurate readings for people with dark skin tones got another look Friday from a panel of experts for the FDA.

But some questions arose regarding number of participants, permissible variance in measurements

Advisory panel to discuss how to improve device accuracy for patients with darker skin

A new battle is emerging in the fight for health equity, and it's centered on the humble pulse oximeter. On November 1, 2023, 25 state attorneys general sent a letter...

A new battle is emerging in the fight for health equity, and it’s centered on the humble pulse oximeter. On November 1, 2023, 25 state attorneys general sent a letter to the Food and...

BASEL, Switzerland--(BUSINESS WIRE)--#CLDN1--Alentis Therapeutics (“Alentis”), the clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+) tumors and organ fibrosis, announced today the appointment of Tony Mok, Professor of Clinical Oncology at the Chinese University of Hong Kong a...

WASHINGTON — With the widespread use of oxygen saturation in medical practice, a pulse oximeter that works on all skin pigments is crucial, according to an American Thoracic Society International Conference presentation.“[Oxygen saturation is] core to how we think about patients and how they are doing, how healthy they are, how sick they are, whether they are critically ill,”

The U.S. FDA will hold a meeting to discuss the underlying flaw of the oximeter after Health professionals and researchers called out the agency.